The Resoundant, a new imaging device developed by Mayo Clinic researchers that uses sound waves and works with MRI scanners, is expected to hit the U.S. market this fall.
By analyzing the elasticity of tissues as sound waves travel through them, the device can diagnose chronic liver disease and cirrhosis without the need for a biopsy, according to the researchers. They also see the potential for many other uses diagnosing conditions in the brain, heart, lung, thyroid, breast, prostate and many other areas. It is theorized that the device could eventually be used to tell a benign tumor from a malignant one without the need for a biopsy or surgery.
Earlier this year, Richard Ehman, MD, and his team at Mayo started working with Benchmark Electronics in Rochester, Minn., to begin building the device. A wholly owned subsidiary company, not yet named, will manage the project, according to the Post-Bulletin.
Mayo Clinic has already partnered with the two top MRI scanner makers, GE Healthcare and Siemens Medical Solutions, to sell the device and install its software on all new MRI scanners they make, according to the Post-Bulletin.
Jim Potter, director of Mayo Clinic Medical Devices company, told the Post-Bulletin that he expects that the new subsidiary will have an office with approximately 15 to 30 employees within the next five years, depending on sale volumes and customer demands.